We build cell therapies faster than biology

Generative Biology will revolutionize the development of living therapies

But a bottleneck exists in the effective translation of potential therapeutic proteins from in silico design into the atomic world of medicine.

Our Bits to Therapies™ platform solves this bottleneck by screening libraries of de novo protein designs directly in the context of a therapeutic modality. This enables us to design, build, test, and translate cancer cell therapies faster than biology.